openPR Logo
Press release

Pediatric Obesity Market Expected to Experience Major Growth by 2034, According to DelveInsight | VIVUS LLC, Novartis, Rhythm Pharmaceuticals, Jack Yanovski

08-08-2025 02:54 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Pediatric Obesity Market Expected to Experience Major Growth

The Key Pediatric Obesity Companies in the market include - Novo Nordisk, Eli Lilly and Company, VIVUS LLC, Novartis, Rhythm Pharma, Jack Yanovski, and others.

DelveInsight's "Pediatric Obesity Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Pediatric Obesity, historical and forecasted epidemiology as well as the Pediatric Obesity market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Pediatric Obesity market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Pediatric Obesity Market Forecast [https://www.delveinsight.com/sample-request/pediatric-obesity-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Some of the key facts of the Pediatric Obesity Market Report:

*
The Pediatric Obesity market size is anticipated to grow with a significant CAGR during the study period (2020-2034)

*
In September 2024, Novo Nordisk highlighted the effectiveness of its obesity treatment, Saxenda (liraglutide), in children under 12 through positive Phase III trial results. Participants receiving Saxenda experienced an average reduction of 5.8% in body mass index (BMI), whereas the placebo group saw a decrease of only 1.6%. The Phase III trial findings were presented at the European Association for the Study of Diabetes (EASD) conference in Spain.

*
In 2023, around 8 million children aged 5 to 19 were affected by obesity across the 7MM. With ongoing lifestyle trends, this figure is anticipated to rise substantially in the coming years.

*
Research indicates that the prevalence of overweight, including obesity, among children and adolescents aged 5-19 has surged from 8% in 1990 to 20% in 2022. This increase has been observed in both genders, with 19% of girls and 21% of boys classified as overweight in 2022.

*
Among the EU4 and the UK, Germany recorded the highest prevalence of childhood obesity cases, while Spain had the lowest.

*
Rhythm Pharmaceuticals intends to file a supplemental New Drug Application (sNDA) with the US FDA in Q2 2024 to extend IMCIVREE's label to include children aged 2 to 6 years

*
Key Pediatric Obesity Companies: Novo Nordisk, Eli Lilly and Company, VIVUS LLC, Novartis, Rhythm Pharma, Jack Yanovski, and others

*
Key Pediatric Obesity Therapies: WEGOVY (semaglutide), SAXENDA (liraglutide), Tirzepatide, VI-0521, Sandostatin LAR, Setmelanotide, Orlistat, and others

*
The Pediatric Obesity market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Pediatric Obesity pipeline products will significantly revolutionize the Pediatric Obesity market dynamics.

Pediatric Obesity Overview

Pediatric obesity refers to the condition of having excess body fat in children and adolescents. It is a complex medical condition characterized by an abnormal or excessive accumulation of fat that may negatively affect a child's health and well-being.

Get a Free sample for the Pediatric Obesity Market Forecast, Size & Share Analysis Report:

https://www.delveinsight.com/report-store/pediatric-obesity-market [https://www.delveinsight.com/report-store/pediatric-obesity-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Pediatric Obesity Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Pediatric Obesity Epidemiology Segmentation:

The Pediatric Obesity market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:

*
Total Prevalence of Pediatric Obesity

*
Prevalent Cases of Pediatric Obesity by severity

*
Gender-specific Prevalence of Pediatric Obesity

*
Diagnosed Cases of Episodic and Chronic Pediatric Obesity

Download the report to understand which factors are driving Pediatric Obesity epidemiology trends @ Pediatric Obesity Epidemiology Forecast [https://www.delveinsight.com/sample-request/pediatric-obesity-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Pediatric Obesity Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Pediatric Obesity market or expected to get launched during the study period. The analysis covers Pediatric Obesity market uptake by drugs, patient uptake by therapies, and sales of each drug.

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Pediatric Obesity Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Pediatric Obesity Therapies and Key Companies

*
WEGOVY (semaglutide): Novo Nordisk

*
SAXENDA (liraglutide): Novo Nordisk

*
Tirzepatide: Eli Lilly and Company

*
VI-0521: VIVUS LLC

*
Sandostatin LAR: Novartis

*
Setmelanotide: Rhythm Pharmaceuticals

*
Orlistat: Jack Yanovski

Discover more about therapies set to grab major Pediatric Obesity market share @ Pediatric Obesity Treatment Landscape [https://www.delveinsight.com/sample-request/pediatric-obesity-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Scope of the Pediatric Obesity Market Report

*
Study Period: 2020-2034

*
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]

*
Key Pediatric Obesity Companies: Novo Nordisk, Eli Lilly and Company, VIVUS LLC, Novartis, Rhythm Pharmaceuticals, Jack Yanovski, and others

*
Key Pediatric Obesity Therapies: WEGOVY (semaglutide), SAXENDA (liraglutide), Tirzepatide, VI-0521, Sandostatin LAR, Setmelanotide, Orlistat, and others

*
Pediatric Obesity Therapeutic Assessment: Pediatric Obesity current marketed and Pediatric Obesity emerging therapies

*
Pediatric Obesity Market Dynamics: Pediatric Obesity market drivers and Pediatric Obesity market barriers

*
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies

*
Pediatric Obesity Unmet Needs, KOL's views, Analyst's views, Pediatric Obesity Market Access and Reimbursement

To know more about Pediatric Obesity companies working in the treatment market, visit @ Pediatric Obesity Clinical Trials and Therapeutic Assessment [https://www.delveinsight.com/sample-request/pediatric-obesity-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Table of Contents

1. Pediatric Obesity Market Report Introduction

2. Executive Summary for Pediatric Obesity

3. SWOT analysis of Pediatric Obesity

4. Pediatric Obesity Patient Share (%) Overview at a Glance

5. Pediatric Obesity Market Overview at a Glance

6. Pediatric Obesity Disease Background and Overview

7. Pediatric Obesity Epidemiology and Patient Population

8. Country-Specific Patient Population of Pediatric Obesity

9. Pediatric Obesity Current Treatment and Medical Practices

10. Pediatric Obesity Unmet Needs

11. Pediatric Obesity Emerging Therapies

12. Pediatric Obesity Market Outlook

13. Country-Wise Pediatric Obesity Market Analysis (2020-2034)

14. Pediatric Obesity Market Access and Reimbursement of Therapies

15. Pediatric Obesity Market Drivers

16. Pediatric Obesity Market Barriers

17. Pediatric Obesity Appendix

18. Pediatric Obesity Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=pediatric-obesity-market-expected-to-experience-major-growth-by-2034-according-to-delveinsight-vivus-llc-novartis-rhythm-pharmaceuticals-jack-yanovski]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pediatric Obesity Market Expected to Experience Major Growth by 2034, According to DelveInsight | VIVUS LLC, Novartis, Rhythm Pharmaceuticals, Jack Yanovski here

News-ID: 4138725 • Views:

More Releases from ABNewswire

Affordable Montreal Canadiens Bell Centre Tickets Online - Save with Promo Code CITY10 on the Best Site CapitalCityTickets.com
Affordable Montreal Canadiens Bell Centre Tickets Online - Save with Promo Code …
Score affordable Montreal Canadiens tickets at Bell Centre! Use promo code CITY10 at CapitalCityTickets.com to save on your seats. Compare ticket options, find the best views, and secure your spot to watch the Canadiens live. Don't miss top NHL action-grab discounted tickets today and enjoy thrilling hockey games without overspending! As the 2025-26 NHL season ignites, the Montreal Canadiens are gearing up to light up the Bell Centre with their signature
Central Florida Notary Express, LLC Expands 24/7 Notary and Mobile Notary Services Across Greater Orlando
Central Florida Notary Express, LLC Expands 24/7 Notary and Mobile Notary Servic …
Winter Park, FL - Central Florida Notary Express, LLC, a 24/7 provider of notary and mobile notary services and certified loan signings, announced expanded same-day coverage across the Greater Orlando area, including Orlando, Winter Park, Maitland, Casselberry, Winter Springs, DeLand, DeBary, Deltona, Sanford, and Lake Mary. The company offers on-site and curbside notarization for jurats, acknowledgments, power of attorney (POA), wills, health care surrogate forms, copy certifications, and real-estate loan
Stafili Wine Cafe Brings the Heart of Greece to New York City - A Sophisticated Destination for Wine Lovers and Food Enthusiasts
Stafili Wine Cafe Brings the Heart of Greece to New York City - A Sophisticated …
Nestled in the vibrant neighborhoods of West Village and Tribeca, Stafili Wine Cafe is redefining New York's dining scene with an unforgettable Greek-inspired experience that blends exceptional wines, authentic Mediterranean cuisine, and an inviting, intimate atmosphere. Whether you're seeking a cozy date night, an after-work escape, or a refined venue for social gatherings, Stafili promises an indulgent journey through the flavors, aromas, and spirit of Greece - without ever leaving
Solar Heroes Launches Premium Solar Control Window Film Solutions in Singapore, Transforming Homes and Workspaces Into Cool, Energy-Efficient Sanctuaries
Solar Heroes Launches Premium Solar Control Window Film Solutions in Singapore, …
As Singapore continues to face soaring temperatures and rising energy costs, Solar Heroes, a premium solar control window film supplier and installer, is stepping up to deliver an innovative solution for homes, offices, and commercial spaces. With a commitment to sustainability, comfort, and performance, Solar Heroes is revolutionizing how Singaporeans experience indoor living through advanced solar control window film technology. More information can be found at https://solarheroes.sg. Singapore - As Singapore

All 5 Releases


More Releases for Pediatric

Chronic Pediatric Conditions Fuels Growth In The Pediatric Radiology Market: An …
The Pediatric Radiology Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Pediatric Radiology Market? The pediatric radiology market, valued at $5.94 billion in 2024, is projected to increase to $6.29 billion in 2025, reflecting a CAGR of 5.9%. Growth
Pediatric Perfusion Market Experiences Growth with Increasing Pediatric Surgerie …
Market Overview Pediatric Perfusion Market size was valued at US$ 575.3 Mn in 2025 and is expected to reach US$ 842.5 Mn by 2032 growing at a compound annual growth rate (CAGR) of 5.6% from 2025 to 2032. Coherent Market Insights has released a comprehensive new report offering an in-depth analysis of the Pediatric Perfusion Market from 2025 to 2032. This study provides reliable global and regional projections, helping stakeholders navigate the
Adorable Smiles Pediatric Dentistry: Pediatric Dentist Corinth, TX
Adorable Smiles Pediatric Dentistry [https://adorablesmilestx.com/] is proud to provide exceptional dental care for children in Corinth, TX. Conveniently located at 3901 FM 2181 Suite 140, the practice is a trusted choice for families looking for pediatric dental services in Corinth TX. With a fun, child-friendly atmosphere, the team ensures that every visit is enjoyable and stress-free for kids. "Our goal is to create a positive dental experience for every child, building
Pediatric Interventional Cardiology Market: Advancements and Opportunities for P …
The report is generically segmented into six parts and every part aims on the overview of the Pediatric Interventional Cardiology Market industry, present condition of the market, feasibleness of the investment along with several strategies and policies. Apart from the definition and classification, the report also discusses the analysis of import and export and describes a comparison of the market that is focused on the trends and development. Along with
Pediatric Neuroblastoma Treatment Market - Redefining Possibilities: Advancement …
Newark, New Castle, USA: The "Pediatric Neuroblastoma Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Pediatric Neuroblastoma Treatment Market: https://www.growthplusreports.com/report/pediatric-neuroblastoma-treatment-market/7681 This latest report researches the industry structure,
Global Pediatric Vaccines Market | Global Pediatric Vaccines Industry | Global P …
The pediatric vaccines market involves of sales of pediatric vaccines and its linked services utilization to provide immunity to infants and children for specific syndromes. Pediatric vaccine is a preparation of killed the microorganisms, living tempered organisms, or living fully virulent organisms that are controlled to encourage the production of antibodies and deliver the immunity against one or numerous diseases among children. Pediatric vaccines are utilized in childhood immunization schedules